NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
12
HERB Quote, Financials, Valuation and Earnings
Last price:
$0.0500
Seasonality move
:
30.26%
Day range:
$0.0500 - $0.0500
52-week range:
$0.0241 - $0.2200
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.04x
Volume:
--
Avg. volume:
15.2K
1-year change:
16.28%
Market cap:
$7.9M
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingYasheng Group has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Yasheng Group has an estimated downside of -- from its current price of $0.0500.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.0500.
Fair Value
-
According to the consensus of 0 analysts, Yasheng Group has -- downside to fair value with a price target of -- per share.
HERB vs. S&P 500
-
Over the past 5 trading days, Yasheng Group has underperformed the S&P 500 by -11.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Yasheng Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Yasheng Group revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Yasheng Group reported revenues of --.
Earnings Growth
-
Yasheng Group earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Yasheng Group reported earnings per share of --.
Enterprise value:
52.1M
EV / Invested capital:
--
Price / LTM sales:
0.01x
EV / EBIT:
0.46x
EV / Revenue:
0.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.16x
Price / Operating cash flow:
0.02x
Enterprise value / EBITDA:
0.40x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2014-12-31 | 2015-12-31 | |
| Income Statement | ||||||
| Revenue | $1B | $1B | $938.9M | $303.6M | $229.3M | |
| Gross Profit | $143.5M | $142.9M | $119.2M | $50.6M | $25M | |
| Operating Income | $136.7M | $136.9M | $113.1M | $49.1M | $23.3M | |
| EBITDA | $150.5M | $151.6M | $129M | $51.2M | $27.2M | |
| Diluted EPS | $0.86 | $0.88 | $0.71 | $0.30 | $0.14 | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $235.9M | $334.1M | $437.8M | $469.8M | $118.2M | |
| Total Assets | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Current Liabilities | $62.2M | $41.1M | $44M | $37.2M | $99.4K | |
| Total Liabilities | $98.4M | $69.2M | $68.5M | $58.2M | $45.8M | |
| Total Equity | $2B | $2.1B | $2.3B | $2.4B | $212.6M | |
| Total Debt | $21.7M | $14.5M | $24.6M | $21.1M | $45.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2014-12-31 | 2015-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $51.1M | $68.1M | $321M | $24.8M | $278.3M | |
| Cash From Investing | -$43.8M | -$61.9M | -$324.3M | -$25M | -$285.9M | |
| Cash From Financing | -$8.4M | -$5.9M | $2.1M | -$1.8M | $4.8M | |
| Free Cash Flow | $51.1M | $68.1M | $321M | $24.8M | $278.3M | |
HERB
Sector
Market Cap
$7.9M
$348.1M
Price % of 52-Week High
22.73%
73.74%
Dividend Yield
0%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
16.28%
-12.75%
Beta (5-Year)
0.610
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.0571
200-day SMA
Sell
Level
$0.0885
Bollinger Bands (100)
Sell
Level
0.0602 - 0.1202
Chaikin Money Flow
Buy
Level
16.4M
20-day SMA
Sell
Level
$0.0732
Relative Strength Index (RSI14)
Sell
Level
39.3845
ADX Line
Buy
Level
13.7755
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$0.0710
MACD (12, 26)
Sell
Level
-0.0077
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
4.4M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Yasheng Group is a Colorado corporation U.S. company, that conducts business operations in the U.S. , China, Philippine through four segments: Mining, Agriculture. Biotechnology and Blockchain+ IOT. The company's agriculture products include herbal medicine, herbal organic food, ginkgo, songaricum, betel nut, coconut, coffee, wolfberry, hemp, etc. It also designs, develops and markets new technologies related to agriculture and genetic biology.
Stock Forecast FAQ
In the current month, HERB has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HERB average analyst price target in the past 3 months is --.
-
Where Will Yasheng Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Yasheng Group share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Yasheng Group?
Analysts are divided on their view about Yasheng Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Yasheng Group is a Sell and believe this share price will rise from its current level to --.
-
What Is Yasheng Group's Price Target?
The price target for Yasheng Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HERB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Yasheng Group is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HERB?
You can purchase shares of Yasheng Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Yasheng Group shares.
-
What Is The Yasheng Group Share Price Today?
Yasheng Group was last trading at $0.0500 per share. This represents the most recent stock quote for Yasheng Group. Yesterday, Yasheng Group closed at $0.0500 per share.
-
How To Buy Yasheng Group Stock Online?
In order to purchase Yasheng Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.48% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 3% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
